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Introduction: COVID-19 has been a formidable challenge with an already under-resourced health care system. 
Current literature has already identified several risk factors. Both lymphopenia and hyperferritinemia in SARS- 
Cov-2 patients had been reported in the literature but so far no study has been done to find the correlation 
between these two variables. 
Objective: To correlate absolute lymphocyte count with serum ferritin levels in patients with COVID-19 admitted 
in the intensive care unit of a tertiary care hospital.  
Material and Methods: This cross-sectional study was carried out at Fauji Foundation Hospital/Foundation 
University Islamabad from July 2020-December 2020. Data were analyzed on Microsoft excel. The correlation 
between serum ferritin and absolute lymphocyte count was done using the Pearson correlation coefficient and P-
value was calculated. Mean and SD was calculated for age. Frequency and percentage were calculated for 
quantitative variables 
Results: The mean age of the patients was 61 +/- 9 years. The age range was (28-75) years. Patients with 
lymphopenia are shown in the following table I. The mean lymphocyte count was 1.1 +/- 0.2 SD. The mean 
Ferritin value was 1148.5 +/- 60 SD. The Pearson correlation coefficient showed an r value of -0.60 which shows a 
moderate negative correlation. The p-value was < 0.05 which was statistically significant. 
Conclusion: There is a significant negative correlation between lymphocyte count and serum ferritin levels which 
will assist clinicians in the early identification of patients at risk. 
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Introduction 
 
The first case of the novel coronavirus SARS-CoV-2 
was identified in Wuhan China in December 2019. Fast 
forward to April 2021, 133 million cases of COVID 19 
have been reported globally with 4.31 million deaths.1 
The symptoms of COVID-19 ranged from 
asymptomatic to mild-to-severe illness leading to 
death.1 All over the world COVID-19 has led to an 
unprecedented human catastrophe.2 The COVID-19 
infection started to spread across Pakistan in February 
2020.  In countries like Pakistan COVID-19 has been a 
formidable challenge with an already under-resourced 
health care system.2  
The development of a cytokine storm is a potentially 
fatal immune condition characterized by  
hyperactivation of T cells, macrophages, natural killer 
cells, and the overproduction of inflammatory 
cytokines and chemical mediators.3,4 In viral infections, 
the aberrant release of pro-inflammatory factors leads 
to apoptosis of epithelial cells which damages the lung 
microvascular and alveolar epithelial cell barrier, 
leading to vascular leakage, alveolar oedema, and 
hypoxia.5 
Hyperactivated T cells, macrophages, and excess 
production of chemical mediators, inflammatory 
cytokines, and macrophages is the hallmark of a 
potentially life-threatening cytokine storm.3,4 
Apoptosis of epithelial cells occurs due to an aberrant 
release of pro-inflammatory cytokines which leads to a 
cascade of lung damage that includes damage to the 
alveolar as well as microvascular epithelial cell barrier 
leading to vascular leakage and consequently lung 
damage and hypoxia.5 
The massive number of cases with SARS-Cov-2 has 
put tremendous pressure on healthcare systems all 
over the world. Most of the countries have declared a 
health emergency. In these highly challenging times 
and also to reduce the risk of morbidity early warning 
signs may be helpful.6 The early detection of patients 
at risk who develop severe illness may assist in 
delivering proper care and modify treatment 
strategies.  
Current literature has already identified several risk 
factors. Both lymphopenia and hyperferritinemia in 
SARS-Cov-2 patients had been reported in the 
literature but so far no study has been done to find the 
correlation between these two variables. Both 
hyperferritinemia and lymphopenia have been linked 
to diseases severity and increased morbidity and 
mortality among SARS-Cov-2 infected patients. 
Absolute lymphocyte count is a cheap, cost-effective, 
quick test that can assist in risk stratifying these 
patients as early management in this disease is crucial 
to save a patient.7,8,9,10 
The present study aimed to correlate absolute 
lymphocyte count with serum ferritin level an 
inflammatory marker that heralds the risk for disease 
complication or cytokine storm to assist in early 
identification of the disease by picking up these early 
warning signs so that treatment could be curtailed in 
due time and risk of morbidity and mortality due to 
COVID 19 Disease is minimized by early intervention. 
 
Materials and Methods 
 
This cross-sectional study was carried out at ---
removed for blind review---from July 2020-December 
2020. The study was approved by the Ethical Review 
Committee of Fauji Foundation Hospital, Rawalpindi. 
Patients with confirmed COVID-19 infection admitted 
to the intensive care unit of the hospital from 1st July- 
to 31st December 2020 were included in the study. A 
positive COVID-19 patient was the one who had a 
positive real-time polymerase chain reaction (PCR) for 
SARS-CoV-2 by sampling through nasopharyngeal 
swabs. 3 ml of blood is taken for Blood CP in ethylene 
diamine tetraacetic acid-containing vacutainers and 
was run on Sysmex-XN series. For serum ferritin 4 ml 
clotted blood was collected in the plain test tube. 
Serum ferritin was performed on the AXSYM system 
by immunoassay using the AXSYM Ferritin reagent kit 
pack. COVID-19 disease severity classification 
proposed by WHO was used to categorize the patients. 
(WHO COVID-19 interim guidelines).11  
Data were analyzed on Microsoft excel. The 
correlation between parameters was assessed using 
the Pearson correlation coefficient and P-value was 
calculated. Mean and SD was calculated for age. 
Frequency and percentage were calculated for 
quantitative variables. Descriptive statistics were 
computed for all study variables. Categorical variables 
were expressed as count (percentage) and continuous 
variables as a median. P < 0.05 was counted as 
statistically significant. 
Positive cases were stratified into asymptomatic, mild, 
moderate, severe, according to the National Institute of 
Health, Pakistan guidelines. The range for normal 
lymphocyte count is 1.5-4.5 X 109/L,12 the cut-off for 
lymphopenia was < 1X 109/L. Cut off for mild 
lymphopenia < 1 X109/L. Moderate lymphopenia was 
less than 0.8 X 109/L and severe lymphopenia was less 
than 0.5 X 109/L.12 The normal reference range of 
serum ferritin for men was 18-270 ng/ml and for 
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females, 18-160 ng/ml the cut-off for high serum 
ferritin for males is >270 ng/ml and for females, it is > 
160 ng/ml. Generally, levels between 30-300 μg/L for 
men and 15-200 μg/L for women are considered 
normal,13 which reflects the significant variation in 
serum ferritin levels. Mild hyperferritinemia was 
ferritin 300-600ug/L, moderate 600-1000 ug/L, and 




This cross-sectional study was conducted at Fauji 
Foundation Hospital from 1st July till 31st December 
2020. A total of 91 patients diagnosed with COVID-19 
by RT-PCR testing admitted in intensive care units 
with severe and critical diseases were included in the 
study. Out of these 91 patients; 41 were males and 50 
patients were females. The mean age of the patients 
was 61+/- 9 years. The age range was (28-75) years. 
Patients with lymphopenia are shown in the following 
table I. The median nadir lymphocyte count was 0.2 X 
10 9/L. The mean lymphocyte count was 1.1 +/- 0.2 
SD. The mean Ferritin value was 1148.5 +/- 60 SD. 
Figure 1 showing the correlation between lymphocytes 
and ferritin. 
 






Frequency/ Percentage of 
Patients 
1 Normal/Mild 27 (29%) 
2 Moderate  23 (25%) 
3 Severe 41 (45%) 
 








1 Mild /Normal 25 (27%) 
2 Moderate 15 (16%) 
3 Severe 51 (56%) 
 
The Pearson correlation coefficient showed an r value 
of -0.60 which shows a moderate negative correlation. 
The inverse relationship shows higher the ferritin 
lower the lymphocyte count. The p-value was < 0.05 
which was statistically significant. 
 
 
Figure 1: showing the correlation of serum ferritin 
with Lymphocytes where the absolute number of 
lymphocytes are shown on the X-axis and Ferritin 




The SARS-CoV2 disease has led to unprecedented 
demands for health care services, especially in the 
intensive care unit.14 Ferritin is one of the major 
proteins which regulates iron homeostasis and it is a 
clinical biomarker for the status of iron in the body. 15 
Serum ferritin is an acute-phase protein and is raised 
in inflammatory conditions as well as in conditions 
where iron stores are increased.16 Serum iron is the 
main modulator of serum ferritin, its synthesis is also 
regulated by numerous inflammatory cytokines i.e. IL-
6 and IL-1β.17 
In a study done in high-risk patients with COVID 19 
serum ferritin levels strongly correlated with disease 
severity. In this study, all patients who had severe 
disease had a serum ferritin level higher than 500 
ug/L. Our data does have a high serum ferritin level 
in patients with serious disease but not all patients had 
serum ferritin levels higher than 500 ug/L.18  
It was found that serum ferritin levels in patients who 
were having critical COVID-19 disease were 2.6 times 
higher compared to the relatively milder categories. 18 
Its crucial to control cytokine storms in the early phase 
of the disease to reduce morbidity and mortality from 
the disease by giving immunomodulators and 
cytokine antagonists (Gandini). In this regard, a blood 
CP could be an early, readily available and quick, and 
cost-effective screening tool to assess the disease 
severity and for early identification for high-risk 
patients with COVID-19.18 
A study was done to assess the relationship of C- 
reactive protein, serum ferritin, and lactate 
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dehydrogenase at admission with mortality in SARS-
CoV2 infection. Out of all the inflammatory markers 
studies, serum ferritin was found to be one of the most 
significant inflammatory markers to correlates with 
disease severity in COVID-19 patients. A serum 
ferritin level of ≥723 ng/ml had a sensitivity of 95.45% 
and a specificity of 86.57% for predicting mortality.19 
A study did even emphasized the need for risk 
stratification of COVID-19 patients based on serum 
ferritin levels as high or low risk. The high-risk 
patients with high serum ferritin levels in these 
patients had a higher ratio of admission to intensive 
care units.20,21 
A high level of serum ferritin is a constant feature of 
HLH and predicts a poor recovery from COVID-19. 23 
Hyperferritinimea in COVID19 and its association 
with disease severity have been reported in the 
literature. Hyperferritinemia can assist in recognizing 
high‐risk patients and guide physicians to timely 
modify their management plan to control 
inflammation.22,23 Hemophagocytic 
Lymphohistiocytosis is a known complication of many 
viral infections 
In another study done serum ferritin levels remained 
persistently high in patients who died of COVID-19.24 
Hyperferritinemia persisted in almost 38% of the 
especially in those having the critical disease. 24The 
patients who did not survive had higher serum ferritin 
levels compared to those who did not survive with 
COVID-19.25 
Lymphopenia is also reported in the literature. There 
is a definite role of lymphocytes in immune 
homeostasis along with an inflammatory response. 
Four potential mechanisms of lymphopenia in COVID-
19 have been proposed. (1) directly infecting 
lymphocytes leading to lymphocyte death. The ACE2 
receptors are present on Lymphocytes which may act 
as a receptor for coronavirus.26 (2) The fact that 
lymphocytic dysfunction causes direct insult by SARS- 
CoV-2 on the thymus and spleen needs to be 
confirmed through further research. (3) Lymphocyte 
apoptosis can occur due to the dysregulation of 
inflammatory cytokines.27 Hyperlacticedemia could 
lead to reduced lymphocytes as patients who are 
critically ill with COVID-19 are found to have raised 
lactic acid levels28 so the mechanism of lymphopenia 
can be multifactorial.  
A direct correlation between low lymphocyte counts 
and severity of disease and inflammatory markers was 
found (P=0.0014).  It has been established that those 
having severe lymphopenia had a prolonged duration 
of illness. (17.0 days vs. 14.0 days, P = 0.002).29 This is 
in agreement with our study as our patients who had 
severe lymphopenia had extended stays in the hospital 
on an average of 18 days.29 
A meta-analysis also showed a worse outcome in those 
patients who had lymphopenia at the time of 
admission. This study also evaluated the association of 
severity of disease and lymphopenia according to age 
groups and was found to be higher in the elderly as 
compared to middle age and younger populations. 
Lymphopenia can be used as a tool to assess the 
severity of disease and stratify high-risk patients. 30 
In patients with COVID-19, one CBC parameter that 
has shown to be consistently associated with disease 
progression is the absolute lymphocyte count. It was 
also shown that within the first 2 weeks of disease 
onset lymphocytes were reduced to lower than 5%. In 
our study, the degree of lymphopenia was irrespective 
of age or gender as both groups showed lymphocytes 
less than 5%.31 
Lymphocyte count is the most commonly deranged 
CBC parameter inpatient with COVID-19, 
lymphopenia showed in (approximately 35%‐83% of 
patients).32,33  
Lymphopenia is found to be persistently low in the 
severe phase of COVID‐19.32  
The median nadir of the ALC in hospitalized patients 
with COVID 19 was found to be (0.4 × 109/L vs 
1.2 × 109/L)33 which was significantly lower. However, 
the median nadir in our patient was lower than in this 
study which was found to be 0.2 X 109/L. 
A meta-analysis has shown lymphopenia as a poor 
prognostic marker in young patients with COVID-19. 
34 Lymphopenia defined as a lymphocyte count ≤ of 
1100 cells/μL is associated with almost a threefold risk 
of a poor outcome. As compared to an older patient 
the association was found to be stronger in younger 
patients.34 
The correlation between lymphocytes and ferritin is 
shown in figure I and it shows a very moderate 
negative correlation with a correlation coefficient r= -
0.6. The correlation will certainly help in the clinical 
judgment of these patients. 
The strong correlation between these variables also 
established the fact that the pathophysiology between 
the low lymphocyte counts and serum ferritin seems to 
have a common origin. The inflammatory cytokine 
storm plays a primary role in causing lymphopenia. 
Pro-inflammatory cytokines i.e. IL-6 and TNF-α are 
closely correlated with lymphopenia. The patients who 
recover from COVID-19 show almost normal levels of 
these cytokines.35 An autopsy performed on lymphoid 
organs showed massive lymphocyte death which was 
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primarily due to the high levels of IL-6 as well as Fas-
FasL interactions.35  
The strong negative correlation between these 2 
variables (coefficient of -0.60 w) will not just help in 
assessing the condition and risks of the patient with 
COVID 19 but will also help to add any intervention 
and modify the treatment as CBC is a quick cost-
effective test and a low lymphocyte count can help in 
predicting an impending cytokine storm in those 
patients.  
The limitation of the study is the small sample size as 
we only included patients who were admitted to the 
ICU. The other limitation is our hospital primarily 
caters to main women which could not be the true 
representative of gender distribution the males are 




There is a significant negative correlation between 
lymphocyte count and serum ferritin levels which will 
assist in identifying patients at risk and in their early 
identification and prompt management. 
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